Literature DB >> 26648600

Conflict of interest in medical journals.

John Dowden1.   

Abstract

Keywords:  conflict of interest; drug bulletins; drug industry

Year:  2015        PMID： 26648600      PMCID： PMC4654035          DOI： 10.18773/austprescr.2015.001

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  10 in total

1.  Financial associations of authors.

Authors:  Jeffrey M Drazen; Gregory D Curfman
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

Review 2.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

3.  Novel melatonin-based treatments for major depression.

Authors:  Jon Jureidini; Melissa Raven
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

4.  Novel melatonin-based treatments for major depression.

Authors:  Bernard J Carroll
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

5.  Novel melatonin-based treatments for major depression.

Authors:  Celia Lloret-Linares; Jean-François Bergmann; Stéphane Mouly
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

6.  Novel melatonin-based treatments for major depression.

Authors:  Marc Serfaty; Peter W Raven
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

7.  Policies and practices on competing interests of academic staff in Australian universities.

Authors:  Simon Chapman; Bronwen Morrell; Rowena Forsyth; Ian Kerridge; Cameron Stewart
Journal:  Med J Aust       Date:  2012-04-16       Impact factor: 7.738

8.  Conflict of interest guidelines for clinical guidelines.

Authors:  Michael J Williams; Dev A S Kevat; Bebe Loff
Journal:  Med J Aust       Date:  2011-10-17       Impact factor: 7.738

9.  Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.

Authors:  P M McNeill; I H Kerridge; D A Henry; B Stokes; S R Hill; D Newby; G J Macdonald; R O Day; J Maguire; K M Henderson
Journal:  Intern Med J       Date:  2006-09       Impact factor: 2.048

Review 10.  Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.

Authors:  Michelle Roseman; Katherine Milette; Lisa A Bero; James C Coyne; Joel Lexchin; Erick H Turner; Brett D Thombs
Journal:  JAMA       Date:  2011-03-09       Impact factor: 56.272
  10 in total
  2 in total

1.  Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.

Authors:  Christian Bianchi; William Tettelbach; Niki Istwan; Brandon Hubbs; Kimberly Kot; Stan Harris; Donald Fetterolf
Journal:  Int Wound J       Date:  2019-03-12       Impact factor: 3.315

2.  From P-Values to Objective Probabilities in Assessing Medical Treatments.

Authors:  David Kault; Sam Kault
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.